John D. Symanski

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.1K citations · Full text

Cardiomyopathy, Structural Heart Disease, Cardiovascular Disease +2

Improvement in the Assessment of Diastolic Function in a Clinical Echocardiography Laboratory Following Implementation of a Quality Improvement Initiative

Thomas V. Johnson, John D. Symanski, Sanjay R. Patel et al. · Journal of the American Society of Echocardiography · 2011 · 31 citations

Quality Improvement Initiative, Cardiovascular Disease, Cardiology +8

Aficamten for Drug-Refractory Severe Obstructive Hypertrophic Cardiomyopathy in Patients Receiving Disopyramide: REDWOOD-HCM Cohort 3

Anjali Owens, Ahmad Masri, Theodore P. Abraham et al. · Journal of Cardiac Failure · 2023 · 29 citations · Full text

The use of pacemakers in the treatment of cardiomyopathies

John D. Symanski, Rick A. Nishimura · Current Problems in Cardiology · 1996 · 28 citations

Cardiomyopathy, Heart Failure, Structural Heart Disease +4

A Practical Approach to Echocardiographic Imaging in Patients With Hypertrophic Cardiomyopathy

Carol Mitchell, Cody Frye, Madeline Jankowski et al. · Journal of the American Society of Echocardiography · 2023 · 25 citations

Cardiomyopathy, Medical Ultrasound, Health Sciences +11